Emtricitabine Active Not Recruiting Phase 4 Trials for Human Immunodeficiency Virus Type 1 (HIV-1) Infection / Solid Organ Transplant Treatment

Back to Emtricitabine
IndicationsStatusPurposePhase
Active Not RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03360682Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients